Corrigendum to “Pharmacological Basis for Use of Selaginella moellendorffii in Gouty Arthritis: Antihyperuricemic, Anti-Inflammatory, and Xanthine Oxidase Inhibition”

---

In the article titled “Pharmacological Basis for Use of Selaginella moellendorffii in Gouty Arthritis: Antihyperuricemic, Anti-Inflammatory, and Xanthine Oxidase Inhibition” [1], there was a missing grant number. Accordingly, the Acknowledgments section should be corrected as follows:

This work was funded by China Postdoctoral Science Foundation (2016M601237), the Natural Science Foundation Project (30470193), the Scientific Research Foundation Project of the Education Department of Hubei Province (Q20142007), Natural Science Foundation of Hubei Province (2013CFC055), and the Young Plan Project of Hubei University of Chinese Medicine (XJ2014KJ008).